Journal
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY
Volume 20, Issue 1, Pages -Publisher
BMC
DOI: 10.1186/s12958-022-00960-z
Keywords
IMP; Ovary; PCOS; Pregnancy; PE; GDM
Categories
Funding
- Natural Science Foundation from Science and Technology Commission of Shanghai Municipality [17ZR1403100]
Ask authors/readers for more resources
The IMPs, a highly conserved family of RNA binding proteins, play a crucial role in regulating RNA processing and are implicated in various physiological and pathological processes, including female reproductive pathophysiology and diseases such as PCOS, PE, GDM, and gynecological tumors.
Insulin-like growth factor 2 (IGF2) mRNA binding proteins (IMPs) family belongs to a highly conserved family of RNA-binding proteins (RBPs) and is responsible for regulating RNA processing including localization, translation and stability. Mammalian IMPs (IMP1-3) take part in development, metabolism and tumorigenesis, where they are believed to play a major role in cell growth, metabolism, migration and invasion. IMPs have been identified that are expressed in ovary, placenta and embryo. The up-to-date evidence suggest that IMPs are involved in folliculogenesis, oocyte maturation, embryogenesis, implantation, and placentation. The dysregulation of IMPs not only contributes to carcinogenesis but also disturbs the female reproduction, and may participate in the pathogenesis of reproductive diseases and obstetric syndromes, such as polycystic ovary syndrome (PCOS), pre-eclampsia (PE), gestational diabetes mellitus (GDM) and gynecological tumors. In this review, we summarize the role of IMPs in female reproductive pathophysiology, and hope to provide new insights into the identification of potential therapeutic targets.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available